Evidence map›Paper›PMID 40843751›Full record

Observational studyMedical sciences (Basel, Switzerland)2025

Phenotypic and Spatial Characterization of Tumor-Associated Macrophages in Non-Metastatic Seminoma: Association with Local Tumor Progression.

Grigory Demyashkin, Vladimir Shchekin, Dmitriy Belokopytov, Tatyana Borovaya, Ivan Zaborsky, Kadir Safiullin, Oleg Karyakin, Alexey Krasheninnikov, Nikolay Vorobyev, Petr Shegay and 1 more

Abstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Medical sciences (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Grigory DemyashkinDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.ORCID 0000-0001-8447-2600
Vladimir ShchekinDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.ORCID 0000-0003-3763-7454
Dmitriy BelokopytovDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.
Tatyana BorovayaDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.
Ivan ZaborskyDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.
Kadir SafiullinDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.
Oleg KaryakinDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.
Alexey KrasheninnikovDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.
Nikolay VorobyevDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.
Petr ShegayDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.
Andrei KaprinDepartment of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass, 3, 125284 Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SeminomaTesticular NeoplasmsTumor-Associated MacrophagesAdultAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCD68 MoleculeDisease ProgressionHumansMaleMiddle AgedPhenotypeReceptors, Cell SurfaceRetrospective StudiesTumor MicroenvironmentAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCD68 antigen, humanCD68 MoleculeReceptors, Cell SurfaceCD68 and CD163M1 and M2 phenotypesmacrophagesseminomaTAMs

Identifiers

PMID40843751
PMCPMC12371909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.